Eli Lilly shares hammered
Wall Street Breakfast
00:00
Market Pressures and Earnings Overview
This chapter examines Eli Lilly's stock performance after its positive Q2 results and future revenue guidance, amidst concerns about a competitor's drug trial outcomes. It also explores mixed earnings from Warner Brothers Discovery and Fortinet, along with recent labor market data and productivity statistics.
Transcript
Play full episode
